Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study
Ellen Dugan(Center for Disease Analysis), Homie Razavi(Center for Disease Analysis), Sarah Robbins-Scott(Center for Disease Analysis), Siya Ma(Center for Disease Analysis), Ivane Gamkrelidze, Mia J. Biondi(York University), Mindi DePaola(Center for Disease Analysis), Poonam Mathur(Center for Disease Analysis), Zongzhen Cai(Center for Disease Analysis), Devin Razavi‐Shearer(University of London), Shauna Montoya(Center for Disease Analysis), Sarah Blach(Center for Disease Analysis), Jonathan Schmelzer(Center for Disease Analysis), Kathryn Razavi‐Shearer(Center for Disease Analysis), Shyamasundaran Kottilil(University of Maryland, Baltimore), Jordan J. Feld(University of Toronto), Chris Estes(Center for Disease Analysis)
Cited by 63
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
|New England Journal of Medicine|2014|907
Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
|New England Journal of Medicine|2010|560
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539